Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...
Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
14h
Zacks.com on MSNCRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for InvestorsCRISPR Therapeutics AG (CRSP) closed at $41.17 in the latest trading session, marking a -1.84% move from the prior day.
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers ...
2-Year U.S. Treasury Note Continuous Contract $103.363 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $107.703 0.102 0.09% 10-Year U.S. Treasury Note Continuous Contract $110.750 0.141 ...
It earns an Above Average Process Pillar rating. The CRSP US Small Cap Index excludes the largest 85% and smallest 2% of US stocks by total market cap. CRSP buckets each eligible constituent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results